Presbyopia drops are now everywhere, but so are the misconceptions. In this MythBusters style episode, Mark Schaeffer, OD, FAAO, breaks down three of the most common concerns Optometrists have about Qlosi: safety and efficacy, when and how to bring it up with patients, and whether it hurts optical sales. Spoiler alert: the data (and real-world experience) tell a very different story. Learn how Qlosi fits seamlessly into modern optometric practice, and why waiting might be costing you more than you think.